Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07035912

Novel PIONEER© Protocol: RCT

Neonatal ICU survivors often face challenges with oral eating, swallowing difficulties, and various aerodigestive issues, and commonly need chronic nasogastric tube feeding or gastrostomy feeding, which escalates socioeconomic burdens, hospital stays, neurodevelopmental delays, and parental suffering. This proposal addresses a vital need in neonatal gastroenterology by studying unique swallowing mechanisms and defining the basis for preventative and corrective therapies through new translational research initiatives via a randomized controlled trial using the novel intervention initiative- Parent Implemented Oral Nutrition, Eating, and Esophageal reflexes Reintegration (PIONEER©) protocol.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Survival rates after neonatal ICU (NICU) care are increasing along with the prevalence of Disorders of Deglutition (DD) among these survivors. DD includes impairments in eating, dysfunctional swallowing, and aerodigestive symptoms which lead to chronic nutritional-, growth- and neurodevelopmental issues. Early, effective, and simple crib-side diagnostic methods and therapies that normalize feeding difficulties during critical development periods are needed to avoid reliance on chronic nasogastric (NG) or gastrostomy tube (g-tube) feeding. These critical diagnostic and rehabilitative challenges are addressed through a randomized controlled trial (RCT) to improve aerodigestive and neurodevelopmental milestones in infants at risk for g-tube use, ultimately reducing public health burden throughout the child's life, which is the long-term goal.

The overarching aim is to implement the Parent-Implemented Oral Nutrition, Eating- and Esophageal rhythms Reintegration (PIONEER) program initiatives to examine the Jadcherla hypothesis. The Jadcherla Hypothesis states that engaging the enteric and central nervous system reflexes early, persistently, and safely in tube-fed infants will result in consistent programmed activation of the deglutition process, swallowing-airway interactions, peristaltic reflexes, and autonomic regulation that will advance neuroplasticity, learning and memory.

The central hypothesis is that the activatable aerodigestive reflex mechanisms are vital in managing oral eating skills, and the independent feeding outcomes (i.e., without a G-tube) depend on intervention strategies.

The rationale is that identifying successful outcomes that are scientifically driven will lay the foundation for scalable protocols. In this RCT, the effect of Parent Implemented Oral Nutrition, Eating, Esophageal reflexes Reintegration (PIONEER©) protocol on clinical and mechanistic outcomes will be examined. Therefore, the impact of the PIONEER© protocol will be tested against the standard of care by completing two specific aims: 1) Compare the efficacy of the randomized intervention by examining the hypothesis that the PIONEER© approach is more effective at achieving the primary outcome of successful oral feeding without requiring a G-tube at NICU discharge. 2) Determine and compare the longitudinal pathophysiological mechanisms in assessing the superiority in achieving the primary outcome by testing the hypothesis that infants who follow the PIONEER© protocol will have more effective mechanisms for restoring and adapting their aerodigestive reflexes.

High-resolution manometry will be used to identify differences between the two study arms concerning the sensory-motor characteristics of aerodigestive reflexes.Completion of the proposed aims will provide opportunities for scalable and generalizable approaches to improve feeding safety and efficiency, while helping infants achieve essential developmental milestones and reducing the socioeconomic burden.

RELEVANCE: This proposal addresses a critical gap for infants who require chronic tube feeding. Completing the proposed aims will result in paradigm shifting methods to optimize oral intake while decreasing the duration of chronic NG tube feeding or preventing g-tube feeding. New evidence-based standardized guidelines will emerge from this study that have the potential for scalability, improving infant feeding-intake methods, growth, and maturation, thereby, alleviating chronic eating difficulties, delayed neurodevelopmental consequences, and public health burden.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Nasogastric tube fed infants referred for diagnostic manometry and Gastrostomy tube planning evaluations.
  • Physiologically stable convalescing infants on full enteral feeds at greater than or equal to 37.0 weeks and less than 46 weeks postmenstrual age.
  • Presence of aerodigestive reflexes on diagnostic manometry.

Exclusion criteria

  • Potentially lethal congenital or chromosomal anomalies
  • Craniofacial defects (cleft lip or palate)
  • History of GI surgery, ENT surgery, or neurosurgery
  • Need for supplemental respiratory support of >2 LPM

Treatment and study plan

PIONEER Protocol

Combination Product
  • Oral nutritive stimulus with every feed (minimum 5mL)
  • Esophageal stimulation with up to 15 stimulations given at least 5 times per week with stimulation catheter
  • High resolution esophageal manometry as much as weekly if feasible throughout protocol
  • Parent biofeedback (during manometry studies) and education on at least a weekly basis with focus on their participation in oral feeding

Primary outcomes

  1. Presence or Absence of Gastrostomy Tube

    Time frame: around 4 weeks after initial diagnostic study or until discharge (can be sooner)

    Primary outcome is successful oral feeding without G-tube measured at the Primary Endpoint of discharge. This determination allows us to test the effect of interventions during a 4 week-period, continued residual effects after 4 weeks, and parental comfort with the collaborative decision of feeding method at discharge.

  2. Change in Aerodigestive Reflexes

    Time frame: around 4 weeks after initial diagnostic study

    Primary outcome is the change in the recruitment of sensory-motor characteristics, and magnitude of aerodigestive reflexes at rest and upon stimulation that are assessed at the repeat manometry study at ~4 weeks, and compared among and between the two arms, testing the effects of intervention protocol.

Secondary outcomes

  1. Parent reported stress and comfort level

    Time frame: up to 1 year

    Parent questionnaire

  2. Length of Hospital Stay

    Time frame: at discharge

    Length of Hospitalization from birth to discharge.

  3. Growth Metrics

    Time frame: until 1 year corrected age

    Weight, Length and Head Circumference measurements until 1 year corrected age.

  4. Neurodevelopment

    Time frame: 1-2 years

    Bayley scores obtained from electronic medical records.

  5. Longterm Feeding Outcomes

    Time frame: until 1 year corrected age

    Feeding method will be assessed during the first year of life as this will help to understand the feeding rehabilitation for those discharged on tube feeding.

Study contacts

Contact information is provided by the study sponsor or research team.

Erika K Osborn

CONTACT

[email protected]

6143556667

Patty Luzader

CONTACT

[email protected]

6143556697

Sponsors and collaborators

Lead sponsor

Nationwide Children's Hospital

Other

Registry information

Official study title

Randomized Controlled Trial Evaluating the Impact of a Novel Parent Implemented Oral Nutrition, Eating, and Esophageal Reflexes Reintegration Program on Hospitalized Infants With Feeding Challenges

Important dates

Study start
2026
Primary completion
2031
Study completion
2032
First posted
Jun 25, 2025
Registry last updated
Jan 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.